borderline significantp = 0.0595
After additional adjustments for diabetes, hypertension, and dyslipidemia (Model 5), as well as chronic kidney disease (Model 6), the associations were slightly attenuated but remained significant for the PU-persistent group (aHR: 1.27; 95% CI, 1.13–1.42; p = 0.0008), became borderline significant for the PU-developed group (aHR: 1.07; 95% CI, 1.00–1.16; p = 0.0595), and were not significant for the PU-recovered group (aHR: 1.06; 95% CI, 0.98–1.14; p = 0.1543) (p for trend < 0.0001) (Model 6 of Table 2 ).